Drawing for ADVANTICE HEALTH

USPTO serial 88384014

ADVANTICE HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BETTS, MARCYA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADVANTICE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Felicia G. Traub, Esq.

Felicia G. Traub, Esq. Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 S. Wacker DriveSuite 2900Chicago, IL 60606-5896

Goods and services

ClassDescriptionStatusFirst use
003Cosmetics; foot care preparations, namely, non-medicated foot cream; non-medicated cosmetical skin care creams and lotions, non-medicated skin care preparation, namely, gels, facial foam cleansing preparation, body sprays, pumice pastes and powders for use on the skin, nails or scalp, all of the aforementioned not for medical use; facial cleansers; skin creams; non-medicated soaps for personal use; non-medicated foot cleaning preparations, namely, foot powder; deodorants for feet; foot deodorant sprays for treating conditions of the nails and skin; non-medicated emollient creams for treating conditions of the nails, skin or scalp; nail-care preparationACTIVE—
005Pharmaceutical preparations for the purpose of treating skin, scalp and nail conditions, fungal and bacterial infections, joint pain, muscle pain, cough, congestion, sinus, cold, flu and allergy symptoms, in the fields of dermatology, gerontology and aging, urology, gynecology, oncology, pediatrics, infectious diseases, pain relief, arthritis and osteoarthritis; disinfectant preparations, namely, pharmaceutical preparations with antimicrobial, emollient and ceratolytic properties in the form of liquids, gels, creams, lotions, sprays, foams or plaster patches for treating warts and other lesions of the epidermis and to loosen or dissolve dry, flakey, callused, and scaly skin or scalp; dermatological preparations for medical use; medical preparations for the treatment of dandruff; medicated dandruff shampoo; medicated dandruff conditioner; medical preparations for the treatment of psoriasis, atopical eczema; medical preparations for the treatment and prevention of acne, athletes foot and other dermatological foot conditions, vaginal fungal infection and other fungal infections; medical preparations for the treatment of joint pain and muscle pain; medicated bath preparations; emollient creams for medical purposes; pharmaceutical preparations for treatment of actinic keratosis; acne care preparations, namely, acne treatment preparationsACTIVE—
010Medical devices for the application and/or dosing of medicines for the treatment or prevention of skin diseases and infections of the mucous membranes; surgical compresses pre-treated with preparations for treating fungal infectionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 10, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 9, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 16, 2023EX5GSOU EXTENSION 5 GRANTED—
Mar 16, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 6, 2023EXT5SOU EXTENSION 5 FILED—
Mar 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 31, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 29, 2022EX4GSOU EXTENSION 4 GRANTED—
Aug 29, 2022EXT4SOU EXTENSION 4 FILED—
Aug 29, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2022EX3GSOU EXTENSION 3 GRANTED—
Feb 7, 2022EXT3SOU EXTENSION 3 FILED—
Feb 7, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 1, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 1, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 31, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 27, 2021EX2GSOU EXTENSION 2 GRANTED—
Aug 27, 2021EXT2SOU EXTENSION 2 FILED—
Aug 27, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 22, 2021EXT1SOU EXTENSION 1 FILED—
Feb 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 8, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 14, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 11, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jun 10, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 10, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 10, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 31, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 31, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 31, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2020ALIEASSIGNED TO LIE—
Dec 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2019DOCKASSIGNED TO EXAMINER—
Apr 30, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 16, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance